On this episode, I discuss umeclidinium pharmacology, adverse effects, patient education pearls, and drug interactions.

Umeclidinium is used in the management of COPD. Below is an excellent quick overview of the COPD guidelines from pyrls.com – You can get the full PDF by signing up for a free account at pryls.com/rlp

Umeclidinium is a long-acting anticholinergic (anti-muscarinic) LAMA and as you can see from the figure above drugs from this class are frequently used in COPD management.

The brand name of umeclidinium is Incruse Ellipta. Ellipta refers to the device and not the drug umeclidinium.

Be sure to check out our free Top 200 study guide – a 31 page PDF that is yours for FREE!

amzn_assoc_placement = "adunit0";
amzn_assoc_search_bar = "true";
amzn_assoc_tracking_id = "meded101-20";
amzn_assoc_ad_mode = "manual";
amzn_assoc_ad_type = "smart";
amzn_assoc_marketplace = "amazon";
amzn_assoc_region = "US";
amzn_assoc_title = "My Amazon Picks";
amzn_assoc_linkid = "c9e4a8285c6ab6b47b7d420eb1f12087";
amzn_assoc_asins = "B07G7HT3S4,B096CXLRVB,B09X2B47NM,B0849NR376";